For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Cardlytics Inc (NASDAQ: CDLX) closed at $1.59 in the last session, down -10.92% from day before closing price of $1.78. In other words, the price has decreased by -$10.92 from its previous closing price. On the day, 5.94 million shares were traded. CDLX stock price reached its highest trading level at $1.82 during the session, while it also had its lowest trading level at $1.59.
Ratios:
We take a closer look at CDLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 81.84. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 3.44 whereas as Long-Term Debt/Eq ratio is at 2.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on October 11, 2024, initiated with a In-line rating and assigned the stock a target price of $4.
On August 16, 2024, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $5.
BofA Securities Downgraded its Neutral to Underperform on August 15, 2024, whereas the target price for the stock was revised from $4 to $3.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when DeSieno Alexis sold 26,217 shares for $1.94 per share. The transaction valued at 50,809 led to the insider holds 164,833 shares of the business.
DeSieno Alexis bought 26,217 shares of CDLX for $50,809 on May 15 ’25. On Apr 22 ’25, another insider, Lynton Nicholas Hollmeyer, who serves as the Chief Legal & Privacy Officer of the company, sold 303 shares for $1.51 each. As a result, the insider received 458 and left with 102,119 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 83478816 and an Enterprise Value of 252158800. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 1.29. Its current Enterprise Value per Revenue stands at 0.925 whereas that against EBITDA is -6.278.
Stock Price History:
The Beta on a monthly basis for CDLX is 1.25, which has changed by -0.8032178 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, CDLX has reached a high of $9.48, while it has fallen to a 52-week low of $1.22. The 50-Day Moving Average of the stock is -10.42%, while the 200-Day Moving Average is calculated to be -44.60%.
Shares Statistics:
According to the various share statistics, CDLX traded on average about 870.65K shares per day over the past 3-months and 1559410 shares per day over the past 10 days. A total of 52.17M shares are outstanding, with a floating share count of 49.80M. Insiders hold about 5.16% of the company’s shares, while institutions hold 54.72% stake in the company. Shares short for CDLX as of 1749772800 were 8016566 with a Short Ratio of 9.21, compared to 1747267200 on 8328396. Therefore, it implies a Short% of Shares Outstanding of 8016566 and a Short% of Float of 17.84.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
